Status:
COMPLETED
CENTR(AR): Lungs Moving
Lead Sponsor:
Aveiro University
Collaborating Sponsors:
Programa Operacional Inclusão Social e Emprego (POISE)
Programa Operacional Competitividade e Internacionalização (POCI) - Compete2020
Conditions:
Chronic Respiratory Disease
Lung Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic Respiratory Diseases (CRDs) are associated with substantial morbidity and mortality, ranking as the third leading cause of death worldwide. Pulmonary rehabilitation (PR) is a fundamental evide...
Detailed Description
The Global Burden Disease Study 2017 estimated that 544.9 million people worldwide had a chronic respiratory disease (CRD). Globally, it is estimated that 3.914.196 deaths were due to CRDs in 2017, ac...
Eligibility Criteria
Inclusion
- Clinical diagnosis of a chronic respiratory disease;
- Stable clinical condition (defined as no acute exacerbation or hospitalization in the previous month).
Exclusion
- Signs of cognitive impairment;
- Neoplasic/Immunologic disease or an unstable/significant cardiac (e.g., exertional angina, valvular heart disease, congestive heart failure, etc.), musculoskeletal/orthopaedic, neuromuscular or psychiatric condition limiting ability to exercise or co-operate.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04711057
Start Date
April 1 2021
End Date
December 31 2023
Last Update
January 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Health Sciences of the University of Aveiro (ESSUA)
Aveiro, Portugal, 3810-193